KK
IART icon

KLP Kapitalforvaltning’s Integra LifeSciences IART Stock Holding History

KLP Kapitalforvaltning’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$134K Hold
14,200
– – ﹤0.01% 1968
2025
Q4 		$176K Buy
14,200
+1,600
+13% +$21.3K ﹤0.01% 1883
2025
Q3 		$181K Hold
12,600
– – ﹤0.01% 1863
2025
Q2 		$155K Hold
12,600
– – ﹤0.01% 1878
2025
Q1 		$277K Sell
12,600
-2,500
-17% -$58.8K ﹤0.01% 1597
2024
Q4 		$342K Buy
+15,100
New +$330K ﹤0.01% 1575

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

KLP Kapitalforvaltning's IART Position: Q1 2026 in Review

KLP Kapitalforvaltning held its Integra LifeSciences (IART) position steady in Q1 2026 at 14,200 shares worth $134K. The position accounts for ﹤0.01% of the portfolio, ranked #1968.

KLP Kapitalforvaltning first reported a position in IART in Q4 2024 and has held it in 6 quarters since. The position peaked at $342K in Q4 2024. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • KLP Kapitalforvaltning held 14,200 shares of Integra LifeSciences worth $134K as of Q1 2026.
  • KLP Kapitalforvaltning left its Integra LifeSciences share count unchanged in Q1 2026.
  • Integra LifeSciences made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q1 2026, its #1968 holding.
  • KLP Kapitalforvaltning first reported a position in Integra LifeSciences in Q4 2024 and has held it in 6 quarters since.
  • KLP Kapitalforvaltning's Integra LifeSciences position peaked at $342K in Q4 2024.
  • 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q1 2026, filed 29 Apr 2026.